On www.panoptic.bio, you can now explore the global clinical trial landscape from discovery through valuation in the Terminal.
Inside Terminal, use the Find view to track actively running clinical trials anywhere in the world and identify which companies are developing new assets for specific indications.
The Globe view shows where clinical trial innovation is happening, who is developing each therapy, and where those programs are being studied.
See where in the world clinical trial innovation is happening. Who is developing what new assets for which indications and where?
The Body view maps new therapies by disease system, organ, cellular pathway, and biological target.
Here you can see what disease systems, to the organ and target and cellular level, are targeted by new therapies in clinical trials.
The Catalyst view tracks upcoming clinical trial readouts and pending FDA decisions, including when new results are expected.
For individual programs, Panoptic Bio can also estimate:
Probability of clinical success
Expected development timelines
Asset valuation
Risk-adjusted net present value
https://www.panoptic.bio/get-access
Compute the probability of success for ongoing clinical trials
Compute the valuation and risk-adjusted Net Present Value (NPV) for ongoing clinical trials
Together, these tools provide a unified view of what is being developed, where innovation is happening, what events are approaching, and which clinical programs may create the most value.
Apply for access
Approved applicants start with credits that can be applied toward Deep Insight Reports, Probability of Success, and rNPV valuation on any asset in the registry.
https://www.panoptic.bio/get-access